About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

FDA Issues Warning on Rare Muscle Injury

by Rajashri on August 12, 2008 at 5:10 PM
Font : A-A+

 FDA Issues Warning on Rare Muscle Injury

The U.S. Food and Drug Administration has warned that patients using a combination of simvastatin and anti-arrhythmia medicine amiodarone could suffer a rare fatal muscle injury.

The injury called rhabdomyolysis may lead to kidney failure or even death.

Advertisement

The FDA said it had already warned about this condition in 2002, but that patients were still being prescribed this combination.

Source: Medindia
RAS/L
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Top 7 Benefits of Good Oral Hygiene
Healthy and Safer Thanksgiving 2021
Long-Term Glycemic Control - A Better Measure of COVID-19 Severity
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.


Recommended Reading
Procedure Makes Mismatched Kidney Transplant Tolerable
In a trial of an experimental protocol designed to induce tolerance to HLA mismatched kidney ......
Study Finds Genes Responsible for Itchy Skin
Study discovers that defective skin gene in people with an inherited skin disorder, which causes ......

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use